Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Masimo's Business Segments

Masimo's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
1
Per the company's own filing, this quarter
Largest Segment
Health Care
100% of revenue
Total Revenue
$ 403
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/MASI/segments
https://api.csimarket.com/api/v1/companies/MASI/geographic
https://api.csimarket.com/api/v1/companies/MASI/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

100%largest
  • Health Care100%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Health CareQ1 FY2026$ 403100%-

Description of Masimo

Masimo Corporation is a publicly traded medical technology company that was founded in 1989 by Joe Kiani. Its headquarters is located in Irvine, California, and it is considered one of the leading innovators in the healthcare industry. Masimo has a global presence and operates in over 130 countries.

Masimo's primary focus is on developing and manufacturing innovative solutions to improve patient outcomes and reduce healthcare costs. The company produces a range of products that include patient monitoring systems, pulse oximeters, sensors, and other medical devices. Masimo's products are used in hospitals, clinics, home healthcare settings, emergency medical services, military and veterinary settings.

One of Masimo's most famous inventions is the Signal Extraction Technology (SET), which is a patented technology that revolutionized pulse oximetry. Pulse oximetry is a non-invasive method of measuring a person's oxygen saturation levels, and SET technology significantly improves the accuracy and reliability of this measurement, preventing misdiagnosis and unnecessary interventions.

Masimo has received several prestigious awards and recognition for its innovative products and services. In 2021, Masimo was ranked as one of the World's Most Innovative Companies by Forbes, an accolade that the company has received multiple times in the past.

The company's growth has been fueled by its continuous investments in research and development. Masimo has a robust pipeline of new products and services in development that are designed to improve patient outcomes and quality of care while reducing healthcare delivery costs.

Furthermore, Masimo is also committed to sustainability and social responsibility. The company's sustainability program includes initiatives to reduce its carbon footprint, increase recycling, and minimize waste. It also supports various charitable organizations globally, providing life-saving medical equipment, supplies, and medicine to people in need.

Overall, Masimo Corporation is considered a trailblazer in the medical technology industry, with an exceptional track record of developing and delivering innovative solutions that revolutionize the healthcare industry. Its commitment to sustainability and social responsibility makes it a standout business in its field.
Masimo Corp is a leading global innovator in noninvasive monitoring technologies that enhance patient safety and improve clinical outcomes. The companys operations are categorized into two primary segments, each of which encompasses a diverse range of products and services designed for both medical professionals and patients.

Segments:

1. Masimo Signal Extraction Technology (SET) Segment:
- The Masimo SET Segment is focused on the development, manufacturing, and sales of a suite of pulse oximetry products that leverage proprietary Signal Extraction Technology. This technology enhances the accuracy and reliability of noninvasive measurements, enabling precise monitoring of patients in various settings, including hospitals, ambulatory surgical centers, and home healthcare environments. The products in this segment provide critical information by measuring:
- Arterial Oxygen Saturation (SpO2): The percentage of oxygen-saturated hemoglobin in the blood.
- Pulse Rate: The number of heartbeats per minute.
- Signal Quality: An assessment of the quality of the signal received, which reflects the reliability of the measurement.

2. Masimo Noninvasive Patient Monitoring (NPM) Segment:
- This segment includes a comprehensive range of noninvasive monitoring technologies, particularly the Masimo Rainbow SET Pulse CO-Oximetry products. These advanced systems enable healthcare providers to measure multiple blood parameters without invasive procedures, which is essential for the monitoring of patients’ health status. Key features of this segment include:
- Hematology parameters: Measurements of hemoglobin levels, which are critical for diagnosing conditions like anemia.
- Oxygen Saturation: Accurate monitoring of blood oxygen levels.
- Carboxyhemoglobin and Methemoglobin levels: Monitoring for carbon monoxide exposure and other hemoglobin variants, facilitating the management of potential poisoning or other respiratory conditions.

Products:

- Masimo SET Pulse Oximetry Products:
- These products cater to diverse clinical environments with multiple models optimized for various applications. They are designed to provide reliable and accurate readings for healthcare professionals managing patients in critical care, operating rooms, emergency departments, and general medical wards, as well as for home healthcare situations.

- Masimo Rainbow SET Pulse CO-Oximetry Products:
- This product line extends the capabilities of pulse oximetry, enabling healthcare professionals to obtain comprehensive information about a patient’s blood composition and condition. It is particularly useful for diagnosing and managing complex medical conditions such as respiratory complications, chronic lung diseases, and instances of suspected carbon monoxide poisoning.

- Root Patient Monitoring and Connectivity Platform:
- The Root platform integrates various monitoring devices and allows for real-time data consolidation. It supports clinicians in making informed decisions with an automated evaluation of clinical parameters and metrics. This platform not only enhances patient assessment and monitoring but also aids in increasing overall clinical efficiency by streamlining data access and management across different care settings.

Services:

- Masimo Patient SafetyNet:
- This advanced service provides a robust framework for remote patient monitoring. SafetyNet enables continuous surveillance of patients physiological parameters and instantly alerts healthcare providers to any significant changes in a patient’s condition. By facilitating proactive intervention, this service is instrumental in enhancing patient safety and reducing critical event occurrences.

- Masimo Education and Training:
- Masimo is deeply committed to the education and training of healthcare professionals. The company offers a variety of learning resources, including online training modules, live webinars, video tutorials, and hands-on training sessions. These educational initiatives are geared towards ensuring that medical personnel are proficient in utilizing Masimo’s innovative technologies effectively, ultimately aimed at improving patient care outcomes.

- Masimo Connectivity Services:
- This service enhances the efficiency of clinical workflows by ensuring seamless integration of patient physiological data with electronic health record systems, third-party applications, and Masimos proprietary patient management systems. The secure transfer of data is critical for clinical decision-making, retrospective analysis, and longitudinal patient management, thus enabling healthcare providers to deliver better-informed, data-driven care.

In summary, Masimo Corp offers a comprehensive portfolio of noninvasive monitoring solutions and educational support aimed at enhancing patient care across various healthcare settings. Their innovations not only empower clinicians with vital patient data but also contribute to improved clinical outcomes and operational efficiencies.